Advancing Medical AM: Biocompatible Production Capabilities

Unlock the Future of Biocompatible 3D Printing

Stratasys Direct is advancing medical-grade additive manufacturing with validated biocompatible workflows. This white paper explores how two leading technologies—Stereolithography (SLA) and Programmable Photopolymerization (P3™ DLP)—enable scalable, ISO 10993-compliant production for critical medical applications. Backed by rigorous testing on Somos® BioClear and Loctite 3D MED413 Clear, the results confirm safe, reliable processes that support medical OEMs in moving confidently from prototyping to production.

Want the full insights, test data, and regulatory impact analysis?
👉 Fill out the form to download the complete white paper and discover how Stratasys Direct can help you bring safer, compliant medical devices to market faster.